Christoffer Vannas

5PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 11, 2026
PIK3CA mutation testing and alpelisib use in metastatic breast cancer: a real-world data set.

|Sep 11, 2025
The levels of circulating tumor DNA and inflammatory proteins depict the clinical response in a patient with metastatic undifferentiated pleomorphic sarcoma, a case report.

Christoffer Vannas, Mandy Escobar, Margaréta Tanyasiová

|Aug 23, 2024
Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis.

Torben Ek, Raghda R Ibrahim, Hartmut Vogt

|Apr 13, 2024
Treatment Monitoring of a Patient with Synchronous Metastatic Angiosarcoma and Breast Cancer Using ctDNA.

Christoffer Vannas, Mandy Escobar, Tobias Österlund

|Mar 25, 2022
Different HSP90 Inhibitors Exert Divergent Effect on Myxoid Liposarcoma In Vitro and In Vivo.

Christoffer Vannas, Lisa Andersson, Soheila Dolatabadi

Pageof 1

Frequent Collaborators

4 joint publications

Anders Ståhlberg

3 joint publications

Henrik Fagman

3 joint publications

Tobias Österlund

2 joint publications

Martin Dalin